2024 Theme:“Digital Innovations in Medical Affairs: Transforming Patient Outcomes”

Tokyo | Japan

medicalaffairs.org/japan2024

Welcome Letter
Dear Esteemed Colleagues & Guests,On behalf of the organizing committee, it is with great pleasure that we extend a warm welcome to attendees ofthe 2nd Annual Japan Medical Affairs Summit in Tokyo. This exciting event, co-organized by JAPhMed, PhRMAand MAPS, will focus on the major impact digital is having across Medical Affairs disciplines with this yearʼstheme, “Digital Innovations in Medical Affairs: Transforming Patient Outcomes.”
We are thrilled to host this prestigious event, bringing together industry leaders, medical professionals, andexperts from around the globe who will share their expertise and perspectives on a wide range of topics, including
Digital Transformation and the Role of Medical Affairs, Patient Centricity & Continuing Medical Education, How toEstablish the MSL in Japan, Career Development and more. We have designed the program to feature informaland formal presentations, panels and a workshop to encourage open-dialogue, networking and knowledgesharing.
We are confident that you will find this conference to be an invaluable opportunity to learn about the latest trends,
insights, and best practices in Medical Affairs for you to help shape the future of healthcare in Japan.
We look forward to welcoming you in Tokyo!
Best regards,

Yasuyuki Katayama
Medical Affairs
Committee Chair
PhRMA

Shinichi Nishiuma
Vice Chairperson,
Head of MedicalAffairs Committee
JAPhMedVictoria Elegant
President, APAC
MAPS

Co-Organized By
PhRMA
Since the opening in 1987, PhRMAʼs Japan office has actively developed various activities on behalf of its
member companies in Japan. We promote activities focused on direct dialogue with all concerned parties
such as government officials, doctors and other medical staff, media parties and patient organizations.
PhRMA cooperates with the Japan Pharmaceutical Federation, the Japan Pharmaceutical Industry
Association and the European Pharmaceutical Federation to develop activities.
JAPhMedJAPhMed has more than 50 years of history in developing “pharmaceutical medicine” in Japan which isdefined as a medical specialty concerned with the discovery, development, evaluation, licensing andmonitoring of medicines and the medical aspects of their marketing. Based on our mission: “To promote
Pharmaceutical Medicine by enhancing the knowledge, expertise and skills of pharmaceutical professionals
and physicians, thus leading to the availability and appropriate use of medicines for the benefit of patientsand the society.” JAPhMed operates as the Japanese affiliate of the International Federation of Associationsof Pharmaceutical Physicians & Pharmaceutical Medicine (IFAPP).
MAPSThe Medical Affairs Professional Society (MAPS) is the premier non-profit global Medical Affairs organization
FOR Medical Affairs professionals BY Medical Affairs professionals across all different levels of experience/
specialty. Together with over 10,500 Medical Affairs members from 300+ companies globally, MAPS istransforming the Medical Affairs profession to increase its value to patients, HCPs, industry and society.
MAPS transforms Medical Affairs organizations and Medical Affairs professionals globally by: speaking as
the single voice of the Medical Affairs profession; defining the current and future practice of Medical Affairs;
being the global community for Medical Affairs professionals; and leveraging collective thought leadershipto train the next generation of Medical Affairs leaders.

This Summit is Endorsed by DIA Japan

Distinguished Advisory BoardYasuyuki Katayama
Associate Vice President Scientific
Advisor & Medical Affairs Committee
Chair
MSD K.K. / PhRMA

Shinichi Nishiuma
Chief Medical Officer & Vice
Chairperson, Head of Medical
Affairs Committee
Aculys / JAPhMed

Victoria Elegant
President, APAC
MAPS

Takeshi (George) Imaoka
Associate Vice President-Medical,
Diabetes Products, Japan Drug
Development & Medical
Affairs & Medical Affairs Committee
Eli Lilly Japan K.K. / PhRMA

Michiko Tomiyasu
Senior Manager, MSL Excellence,
MO, Medical Affairs Division / MSL
Training Curriculum Lead
Alexion Pharma / JAPhMedToshifumi Suzuki
MSL / Medical Affairs
Committee Working Group 3,Leader
MSD K.K. / PhRMAYi PiaoDirector, Scientific Innovation /Working Group 1 Leader, MedicalAffairs Committee
Gilead Sciences K.K. / PhRMA

Takashi Kanemitsu
Scientific Communications /Working Group 3, Medical Affairs
Committee
Amgen K.K. / PhRMA

Yoichi Inoue
Senior Medical Director,
Immunology/PH/Neuroscience,
Medical Affairs Japan
Janssen Pharmaceutical K.K.

Agenda & Schedule of Events
Monday, April 22 - General Session*Simultaneous Translation in Japanese/English will be provided
for the entire General Session on April 22.

8:30 - 8:55

Registration, Networking & Exhibition Hall Open

8:55 - 9:00

Welcome Remarks
Shinichi Nishiuma
Vice Chairperson, Head ofMedical Affairs Committee
JAPhMedChief Medical OfficerAculys

9:00 - 9:30

Yasuyuki Katayama
Medical Affairs Committee Chair
PhRMA
Associate Vice President
Scientific Advisor
MSD K.K.

Victoria Elegant
APAC President
MAPS

The Critical Impact in Medical Affairs of Cross Functional Alignment to Impact Patient Outcomes
Matthew Robson
Corporate Officer,
Chief Medical Officer
Novartis Pharma K.K.

Leo LeePresident and Representative Director
Novartis Pharma K.K.

Agenda & Schedule of Events
Monday, April 22 - General Session

9:30 - 10:30*Simultaneous Translation in Japanese/English will be provided
for the entire General Session on April 22.

The Impact of Digital on Medical Affairs
Moderator:
Victoria Elegant
President, APAC
MAPS

10:30 - 11:00

Panelists:
Yasuyuki Katayama
Medical Affairs Committee Chair
PhRMA
Associate Vice President
Scientific Advisor
MSD K.K.

Shinichi Nishiuma
Vice Chairperson, Head of Medical
Affairs Committee
JAPhMedChief Medical Officer
AculysPauline Ng
Vice President, Head of Medical
Affairs Japan
Janssen Pharma K.K.

Shuhei Fujita
Senior Vice President, Head ofMedical Affairs
Astellas Pharma

Networking Break & Exhibits

Helen Lin
Corporate Officer, Medical Affairs
Executive Medical Director
Amgen K.K.

Agenda & Schedule of Events
Monday, April 22 - General Session*Simultaneous Translation in Japanese/English will be provided
for the entire General Session on April 22.

Digital Transformation and the Role of Medical Affairs
Session Moderators:
Takeshi (George) Imaoka
Associate Vice President-Medical, Diabetes Products
Japan Drug Development & Medical Affairs / Vice-Chair, Medical
Affairs Committee
Eli Lilly Japan K.K. / PhRMA

11:00 - 11:15

Bora Erdemli
Principal
ZS Associates

Whatʼs the Impact of Digital and AI on Medical Affairs? Best Practices from Digital Initiatives
Tadashi Umeda
Executive Director, Japan Medical Affairs Capabilities
MSD K.K.

11:15 - 11:30

Whatʼs the Impact of Digital and AI on Medical Affairs? Best Practices from Company Perspective
Akihiro Konishi
Associate Director of Medical Digital Solution, Medical Affairs Capabilities,
Japan Drug Development & Medical Affairs
Eli Lilly Japan K.K.

11:30 - 12:00

Voices from Around the World: Insights from US/EU/APAC Regions
Tamas Koncz
Chief Medical Officer International
Developed Markets, ACCORD/GCAP
Pfizer

12:00 - 12:20

Daniel Ruzicka
Medical Affairs Lead, Asia Pacific & Japan
OrganonHow Digital Thinking Enables Medical Strategy
Bora Erdemli
Principal
ZS Associates

Agenda & Schedule of Events
Monday, April 22 - General Session
12:20 - 13:00*Simultaneous Translation in Japanese/English will be provided
for the entire General Session on April 22.

Q&A and Panel Discussion
Moderator:
Bora Erdemli
Principal
ZS Associates
Panelists:
Tadashi Umeda
Executive Director, Japan Medical
Affairs Capabilities
MSD K.K.

Akihiro Konishi
Associate Director of Medical Digital Solution
Eli Lilly Japan K.K.

Tamas Koncz
Chief Medical Officer International
Developed Markets, ACCORD/GCAP
PfizerTakeshi Imaoka
Associate Vice President-Medical, Diabetes Products
Japan Drug Development & Medical Affairs /Vice-Chair, Medical Affairs Committee
Eli Lilly Japan K.K. / PhRMA

Daniel Ruzicka
Medical Affairs Lead, Asia Pacific & JapanOrganon

13:00 - 13:40

Bento Box Lunch

13:40 - 14:00

Lunch Seminar Sponsored by Syneos Health“Considering the Abilities of Individuals and Organizations Required for Medical Affairs”

Agenda & Schedule of Events
Monday, April 22 - General Session*Simultaneous Translation in Japanese/English will be providedfor the entire General Session on April 22.

Patient Centricity & Continuing Medical Education (CME)
Session Moderators:
Yasuyuki Katayama
Associate Vice President Scientific Advisor &Medical Affairs Committee Chair
MSD K.K. / PhRMA

Toshifumi Suzuki
MSL / Medical Affairs Committee Working Group 3, Leader
MSD K.K. / PhRMA

14:00 - 14:30

Change From the Perspective of the Patient

14:30 - 15:00

Challenges of Continuing Medical Education (CME) in Japan

15:00 - 15:30

Q&A and Panel Discussion

Hiromi Todoroki
Chairperson
NPO Kibou-no-kai

Tamio Teramoto
Director of Teikyo Academic Research Center (TARC) & Regent
Teikyo University
Moderator:
Yasuyuki Katayama
Associate Vice President Scientific Advisor &Medical Affairs Committee Chair
MSD K.K. / PhRMA
Panelists:
Hiromi Todoroki
Chairperson
NPO Kibou-no-kai

15:30 - 16:00

Networking Break & Exhibits

Tamio Teramoto
Director of Teikyo Academic
Research Center (TARC) & Regent
Teikyo University

Agenda & Schedule of Events
Monday, April 22 - General Session*Simultaneous Translation in Japanese/English will be provided
for the entire General Session on April 22.

How to Establish the MSL in Japan
Session Moderators:
Yasuyuki Katayama
Associate Vice President Scientific Advisor &Medical Affairs Committee ChairMSD K.K. / PhRMA

16:00 - 16:20

Toshifumi Suzuki
MSL / Medical Affairs Committee Working Group 3, Leader
MSD K.K. / PhRMA

Challenges From the Perspective of Pharmaceutical Industry
Akira Noguchi
Director of MSL, Medical Affairs Dept. Integrated Disease Care Division /Vice Chairperson of Medical Affairs Expert Committee
Shionogi & Co. Ltd. / Japan Pharmaceutical Manufacturerʼs Association (JPMA)

16:20 - 16:40

Challenges and Suggestions From the Perspective of a Former MHLW Officer

16:40 - 17:10

Challenges and Suggestions From the Perspective of Academia

17:10 - 17:30

Challenges From the Perspective of Thought Leader

Takamasa HorioPartnerMori Hamada & Matsumoto

Katsunori Yamaura
Professor, Center for Social Pharmacy and Pharmaceutical Care Sciences, Division of Social Pharmacy
Keio University

Tatsunori Shimoi
Head of Physician, Department of Medical Oncology,
Head of Strategic Promotion Section, Department of International Medicine and Advanced Care,
Staff Physician, Rare Cancer Center
National Cancer Center HospitalAgenda & Schedule of Events
Monday, April 22 - General Session
17:30 - 18:25

Panel Discussion

Moderator:
Yasuyuki Katayama
Associate Vice President Scientific Advisor &Medical Affairs Committee Chair
MSD K.K. / PhRMA
Panelists:
Akira Noguchi
Director of MSL, Medical Affairs Dept. Integrated
Disease Care Division / Vice Chairperson ofMedical Affairs Expert Committee
Shionogi & Co. Ltd. / JPMA
Takamasa HorioPartnerMori Hamada & Matsumoto
Tatsunori Shimoi
Head of Physician, Department of Medical Oncology,
Head of Strategic Promotion Section, Department ofInternational Medicine and Advanced Care,
Staff Physician, Rare Cancer Center
National Cancer Center Hospital

18:25 - 18:30
18:30 - 19:30*Simultaneous Translation in Japanese/English will be provided
for the entire General Session on April 22.

Michiko Tomiyasu
Senior Manager, MSL Excellence, MO,
Medical Affairs Division / MSL Training Curriculum LeadAlexion Pharma / JAPhMed
Katsunori Yamaura
Professor, Center for Social Pharmacy and Pharmaceutical CareSciences, Division of Social Pharmacy
Keio University

General Session Closing Remarks

Evening Cocktail Reception
We would be honored to have you join us at our Evening Cocktail Reception, which will take place directly at the meetingvenue. After a long day of productive discussions, we look forward to opportunities to make valuable business connections.
Over wine, beers, soft drinks and finger foods, you'll have the chance to meet with industry peers, chat with thought leaders,and expand your network. We can't wait to see you there!

Agenda & Schedule of Events
Tuesday, April 23 - Career Development Workshop*The Career Development Workshop on April 23 will be held in Japanese and translation to English WILL NOT be provided.

8:30 - 9:00

Career Development Workshop Registration

9:00-13:00

Navigating Your Medical Affairs Career: A Workshop on Growth and Development
Are you looking to take your medical affairs career to the next level? This interactive workshop is designed to help younavigate the often complex landscape of professional development in the medical affairs field. Our expert speakers will
guide you through the key stages of career growth, from understanding your strengths and opportunities to developinga personalized plan for success.
Moderators:
Yi Piao
Director, Scientific Innovation Lead / Working
Group 1 Leader, Medical Affairs Committee
Gilead Sciences K.K. / PhRMA

Takashi Kanemitsu
Scientific Communication / Medical Affairs Committee
Working Group 3
Amgen / PhRMA

Yoichi Inoue
Senior Medical Director, Immunology/PH/Neuroscience, Medical Affairs Japan
Janssen K.K. / JAPhMed

13:00

Speakers:
Takahiro Katayama
Senior Manager, Medical Lead (Immunology),
Innovative Medicine Medical, Japan Medical
Bristol-Myers Squibb K.K.

Michiko Tomiyasu
Senior Manager, MSL Excellence, MO,Affairs Division / MSL Training Curriculum Lead Medical
Alexion Pharma / JAPhMed

Tomoko Takami
Senior Director, Head of Oncology Medical Affairs
Gilead Sciences K.K.

Makio Kamida
Director, Health Care Compliance
Janssen Pharmaceutical K.K.

Kotone Matsuyama
Professor, Department of Health Policy Management
Nippon Medical Hospital

Mitsuhiro Suzuki
Oncology Medical Affairs Hematology LeadPfizer Japan Inc.

Japan Medical Affairs Summit Ends

Speaking Faculty
Shinichi Nishiuma
Chief Medical Officer & Vice
Chairperson, Head of MedicalAffairs CommitteeAculys / JAPhMed

Yasuyuki Katayama
Associate Vice President
Scientific Advisor & MedicalAffairs Committee Chair
MSD K.K. / PhRMA

Victoria Elegant
APAC President
MAPS

Helen Lin
Corporate Officer, Medical Affairs,
Executive Medical Director
Amgen K.K.

Michiko Tomiyasu
Senior Manager, MSL Excellence,
MO, Medical Affairs Division / MSL
Training Curriculum Lead
Alexion Pharma / JAPhMed

Katsunori Yamaura
Professor, Center for Social
Pharmacy and Pharmaceutical
Care Sciences, Division of Social
Pharmacy
Keio University

Jan van Overbeeke
Partner
McKinsey & Company

Toshifumi Suzuki
MSL / Medical Affairs Committee
Working Group 3, Leader
MSD K.K. / PhRMA

Tamas Koncz
Chief Medical Officer, International
Developed Markets, ACCORD/GCAP
PfizerLeo LeePresident and Representative
Director
Novartis Pharma K.K.

Tomoko Takami
Senior Director, Head ofOncology Medical Affairs
Gilead Sciences K.K.

Matthew Robson
Corporate Officer, Chief Medical
Officer
Novartis Pharma K.K.

Pauline Ng
Vice President, Head of MedicalAffairs Japan
Janssen Pharma K.K.

Bora Erdemli
Principal
ZS Associates

Takeshi (George) Imaoka
Associate Vice President-Medical,
Diabetes Products
Japan Drug Development & Medical
Affairs / Vice-Chair, Medical Affairs
Committee
Eli Lilly Japan K.K. / PhRMA

Speaking Faculty
Akihiro Konishi
Associate Director of Medical
Digital Solution
Eli Lilly Japan K.K.

Akira Noguchi
Director of MSL, Medical Affairs
Dept. Integrated Disease Care
Division / Vice Chairperson ofMedical Affairs Expert Committee
Shionogi & Co. Ltd. / JPMA

Hiromi Todoroki
Chairperson
NPO Kibou-no-kai

Takamasa HorioPartnerMori Hamada & Matsumoto

Kotone MatsuyamaProfessor, Department ofHealth Policy Management
Nippon Medical Hospital

Tadashi Umeda
Executive Director, Japan
Medical Affairs Capabilities
MSD K.K.

Mitsuhiro Suzuki
Oncology Medical Affairs
Hematology Lead
Pfizer Japan Inc.

Makio Kamida
Director, Health Care Compliance
Janssen Pharmaceutical K.K.

Daniel Rudicka
Medical Affairs Lead, Asia
Pacific & Japan
OrganonTakahiro Katayama
Senior Manager, Medical Lead
(Immunology), Innovative
Medicine Medical, Japan Medical
Bristol-Myers Squibb K.K.

Tamio Teramoto
Director of Teikyo Academic
Research Center (TARC) & Regent
Teikyo University

Shuhei Fujita
Senior Vice President, Headof Medical Affairs
Astellas Pharma

Tatsunori Shimoi
Head of Physician, Department ofMedical Oncology, Head of Strategic
Promotion Section, Department ofInternational Medicine and Advanced
Care, Staff Physician Rare Cancer
CenterNational Cancer Center Hospital

Registration

Early Bird

Main Session Only (April 22) *Translation for English/Japanese Provided(Ends March 1, 2024)
JAPhMed, MAPS or PhRMA Member BioPharma Company Rate
$125
Non-Member BioPharma Company Rate
$200
Non-Member BioPharma Company Group Rate*$175

Regular(Begins March 2, 2024)

$175
$250
$200

*3 or more attendees from the same company

Non-BioPharma Company Rate
Academic / Hospital Rate

$500
$100

$600
$125

Career Development Workshop Only (April 23) *Workshop in Japanese; English/Japanese translation NOT Provided
Single Rate
$90$100
Main Session + Career Development Workshop (April 22 & 23)
JAPhMed, MAPS or PhRMA Member BioPharma Company Rate
Non-Member BioPharma Company Rate
Non-Member BioPharma Company Group Rate*$200
$275
$250

$250
$325
$275

$575
$150$675$200*3 or more attendees from the same company

Non-BioPharma Company Rate
Academic / Hospital Rate

Register at medicalaffairs.org/japan2024Meeting Venue & AccessNihonbashi Life Science HUB
Address: 1-5-5, Nihonbashi-muromachi, Chuo-ku, Tokyo 103-0022
Muromachi Chibagin Mitsui Building 8F Click Here for Google Maps
Phone: +81 3-6888-8080

Access by JR Line + Tokyo Metro
Tokyo Metro Ginza Line / Hanzomon Line
Directly connected to “Mitsukoshimae” Station
JR Sobu Line Rapid
Directly connected to “Shin-nihonbashi” Station
JR Yamanote Line / Keihin-Tohoku Line / Chuo Line Rapid
9-minute walk from South Exit of “Kanda” Station
9-minute walk from Nihonbashi Exit of “Tokyo” Station

From the 1st basement get into theCOREDO Muromachi 3. Be careful: there
are buildings of “the COREDO Muromachi 1”
and “the COREDO Muromachi 2” that arelocated next to the COREDO Muromachi 3.

Pass through the automatic door ofthe "Muromachi Chibagin Mitsui
Building" office entrance.

Take the elevator to the 8th floor.

Agenda-at-a-Glance

Monday, 22 April - General Sessions

Tuesday, 23 April - Career Development Workshop

08:30 – 08:55
08:55 – 09:00
09:00 – 09:30

08:30 – 09:00
09:00 – 09:15
09:15 – 11:00
11:00 – 11:30
11:30 – 13:00
13:00

09:30 – 10:30
10:30 – 11:00
11:00 – 13:00
13:00 – 14:00
14:00 – 15:30
15:30 – 16:00
16:00 – 18:25
18:25 – 18:30
18:30 – 19:30

Registration & Networking
Welcome Remarks
Fireside Chat: The Critical Impact of Medical
Affairs in Cross-Functional Alignment in
Improving Patient Outcomes
Keynote Panel: Digital Innovations in
Medical Affairs: Transforming Patient
Outcomes
Networking Break & Exhibits
Digital Transformation and the Role ofMedical Affairs
Networking Lunch
Patient Centricity & Continuing Medical
Education
Networking Break & Exhibits
How To Establish the MSL in JapanDay 1 Closing Remarks
Networking Cocktail ReceptionRegistration & Networking
Welcome Remarks
Career Development Workshop
Networking Break & Exhibits
Career Development Workshop
Summit Concludes

Tuesday, 23 April - Medical Heads’ Roundtable
08:30 – 09:00
09:00 – 10:30
10:30 – 11:00
11:00 – 12:00
12:00 – 12:50

Registration & Networking
Talent Management

Networking Break & Coffee
Medical Activity & Impact Measurement

Networking Lunch & Wrap-Up*The Medical Headsʼ Roundtable is an invitation-only session for
Medical Heads from BioPharma companies from Japan andglobal. If you are interested in attending, please send an email tojon.liong@lycheegroup.com.

If you have any questions about Sponsorship, Exhibition or Attendance,
please contact: jon.liong@lycheegroup.com